Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
2,203
-111
-5% -$13K 0.11% 196
2026
Q1
$278K Sell
2,314
-2
-0.1% -$231 0.13% 178
2025
Q4
$244K Buy
+2,316
New +$217K 0.11% 193
2025
Q3
Sell
-4,346
Closed -$344K 222
2025
Q2
$344K Sell
4,346
-68
-2% -$5.41K 0.17% 131
2025
Q1
$396K Buy
4,414
+486
+12% +$45.4K 0.23% 104
2024
Q4
$391K Buy
3,928
+394
+11% +$40.6K 0.22% 103
2024
Q3
$401K Buy
3,534
+29
+0.8% +$3.44K 0.23% 107
2024
Q2
$434K Sell
3,505
-702
-17% -$90.4K 0.27% 83
2024
Q1
$555K Sell
4,207
-1,246
-23% -$154K 0.35% 67
2023
Q4
$594K Buy
5,453
+40
+0.7% +$4.15K 0.42% 57
2023
Q3
$557K Sell
5,413
-60
-1% -$6.47K 0.4% 56
2023
Q2
$631K Buy
5,473
+472
+9% +$53.6K 0.44% 45
2023
Q1
$532K Buy
5,001
+83
+2% +$8.96K 0.38% 58
2022
Q4
$546K Sell
4,918
-469
-9% -$47.9K 0.41% 46
2022
Q3
$464K Buy
5,387
+443
+9% +$39.5K 0.38% 57
2022
Q2
$450K Sell
4,944
-9,337
-65% -$828K 0.41% 63
2022
Q1
$1.17M Buy
14,281
+1,055
+8% +$83.2K 0.26% 83
2021
Q4
$1.01M Buy
13,226
+1,109
+9% +$88.3K 0.28% 72
2021
Q3
$910K Buy
12,117
+6,501
+116% +$494K 0.29% 66
2021
Q2
$437K Sell
5,616
-411
-7% -$30.6K 0.32% 68
2021
Q1
$443K Sell
6,027
-67
-1% -$4.94K 0.36% 61
2020
Q4
$476K Buy
+6,094
New +$466K 0.42% 61

Other funds holding MRK

Latitude Advisors's MRK Position: Q2 2026 in Review

Latitude Advisors reduced its Merck (MRK) stake by 4.8% in Q2 2026, selling an estimated $13K and leaving 2,203 shares worth $283K. The position accounts for 0.11% of the portfolio, ranked #196.

Latitude Advisors first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.17M in Q1 2022. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Latitude Advisors held 2,203 shares of Merck worth $283K as of Q2 2026.
  • Latitude Advisors sold 111 Merck shares in Q2 2026, an estimated $13K.
  • Merck made up 0.11% of Latitude Advisors's portfolio in Q2 2026, its #196 holding.
  • Latitude Advisors first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Latitude Advisors's Merck position peaked at $1.17M in Q1 2022.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Latitude Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.